Trial Outcomes & Findings for Testing Feasibility of Care Coordination and Motivational Interviewing for Women With a Recent Preterm Birth (NCT NCT05120843)
NCT ID: NCT05120843
Last Updated: 2026-01-27
Results Overview
The study team will compare the number of potentially eligible participants to those who are screened for eligibility. The number screened will be defined as the number of people whose are reviewed to approach for enrollment. The number of potentially eligible participants will be considered the number of women with preterm births with Medicaid insurance.
TERMINATED
NA
13 participants
Screening phase (Up to 1 week prior to enrollment)
2026-01-27
Participant Flow
We have included a Table for the screening and enrollment phase of the study because a major goal of the study was to assess feasibility of screening and enrollment procedures, as well as reasons for non-participation. This table, and the numbers included in this table, support calculation of Outcomes 1 - 3. In addition they provide important information about feasibility that are relevant to other research in this area.
Participant milestones
| Measure |
Intervention Arm
This intervention will combine care coordination and motivational interviewing strategies.
Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
|
|---|---|
|
Screening and Enrollment Phase
STARTED
|
49
|
|
Screening and Enrollment Phase
Potentially Eligible on Chart Review
|
28
|
|
Screening and Enrollment Phase
Approached
|
28
|
|
Screening and Enrollment Phase
Confirmed Eligible
|
22
|
|
Screening and Enrollment Phase
Consented and Enrolled
|
13
|
|
Screening and Enrollment Phase
COMPLETED
|
13
|
|
Screening and Enrollment Phase
NOT COMPLETED
|
36
|
|
Intervention Phase
STARTED
|
13
|
|
Intervention Phase
COMPLETED
|
10
|
|
Intervention Phase
NOT COMPLETED
|
3
|
Reasons for withdrawal
| Measure |
Intervention Arm
This intervention will combine care coordination and motivational interviewing strategies.
Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
|
|---|---|
|
Screening and Enrollment Phase
Not eligible on chart review
|
21
|
|
Screening and Enrollment Phase
Not eligible on in-person screening
|
6
|
|
Screening and Enrollment Phase
Too much going on during hospital stay
|
3
|
|
Screening and Enrollment Phase
Perceived services not needed
|
2
|
|
Screening and Enrollment Phase
Recently moved to the area
|
1
|
|
Screening and Enrollment Phase
No reason given
|
3
|
|
Intervention Phase
Lost to Follow-up
|
3
|
Baseline Characteristics
Testing Feasibility of Care Coordination and Motivational Interviewing for Women With a Recent Preterm Birth
Baseline characteristics by cohort
| Measure |
Intervention Arm
n=13 Participants
This intervention will combine care coordination and motivational interviewing strategies.
Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=41 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
13 Participants
n=41 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=41 Participants
|
|
Age, Continuous
|
29.4 years
STANDARD_DEVIATION 5.8 • n=41 Participants
|
|
Sex: Female, Male
Female
|
13 Participants
n=41 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=41 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=41 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
13 Participants
n=41 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=41 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=41 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=41 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=41 Participants
|
|
Race (NIH/OMB)
Black or African American
|
13 Participants
n=41 Participants
|
|
Race (NIH/OMB)
White
|
0 Participants
n=41 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=41 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=41 Participants
|
|
Region of Enrollment
United States
|
13 Participants
n=41 Participants
|
|
Gestational age at delivery
|
33.2 weeks
STANDARD_DEVIATION 3.0 • n=41 Participants
|
PRIMARY outcome
Timeframe: Screening phase (Up to 1 week prior to enrollment)Population: See Participant Flow Section. The screening rate was 100% in that we were able to review all potentially eligible participants as defined here.
The study team will compare the number of potentially eligible participants to those who are screened for eligibility. The number screened will be defined as the number of people whose are reviewed to approach for enrollment. The number of potentially eligible participants will be considered the number of women with preterm births with Medicaid insurance.
Outcome measures
| Measure |
Intervention Arm
n=49 Participants
This intervention will combine care coordination and motivational interviewing strategies.
Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
|
People Who Declined Participation
This outcome involves people who declined to participate in this study
|
|---|---|---|
|
Screening Rate (Feasibility)
|
49 Participants
|
—
|
PRIMARY outcome
Timeframe: Screening phase (Up to one week prior to enrollment)Population: 22 patients were confirmed eligible of which 13 were consented.
The study team will track the proportion of eligible women approached for enrollment who enroll in the study.
Outcome measures
| Measure |
Intervention Arm
n=22 Participants
This intervention will combine care coordination and motivational interviewing strategies.
Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
|
People Who Declined Participation
This outcome involves people who declined to participate in this study
|
|---|---|---|
|
Enrollment Rate (Feasibility)
|
13 Participants
|
—
|
PRIMARY outcome
Timeframe: Screening phase (Up to 1 week prior to enrollment)Population: See also Participant Flow Section
For women who decline enrollment we will ask them, if they are willing, to provide reasons for non-participation and potential study modifications that might have encouraged them to participate. Responses will be tabulated and reviewed for potential themes.
Outcome measures
| Measure |
Intervention Arm
This intervention will combine care coordination and motivational interviewing strategies.
Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
|
People Who Declined Participation
n=9 Participants
This outcome involves people who declined to participate in this study
|
|---|---|---|
|
Reasons for Non-participation (Acceptability)
Recently moved to the area
|
—
|
1 people
|
|
Reasons for Non-participation (Acceptability)
No reason given
|
—
|
3 people
|
|
Reasons for Non-participation (Acceptability)
Too much going on during hospital stay
|
—
|
3 people
|
|
Reasons for Non-participation (Acceptability)
Perceived services not needed
|
—
|
2 people
|
PRIMARY outcome
Timeframe: Enrollment through six monthsPopulation: We counted the participants who completed all study data assessments.
The study team will track the proportion of enrolled participants who complete the intervention and the study assessments.
Outcome measures
| Measure |
Intervention Arm
n=13 Participants
This intervention will combine care coordination and motivational interviewing strategies.
Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
|
People Who Declined Participation
This outcome involves people who declined to participate in this study
|
|---|---|---|
|
Retention Rate (Feasibility)
|
9 Participants
|
—
|
PRIMARY outcome
Timeframe: Enrollment through six monthsThe study team will track the proportion of the baseline, 3-month, and 6-month assessments that are completed.
Outcome measures
| Measure |
Intervention Arm
n=39 Possible assessments
This intervention will combine care coordination and motivational interviewing strategies.
Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
|
People Who Declined Participation
This outcome involves people who declined to participate in this study
|
|---|---|---|
|
Number of Completed Assessments (Feasibility)
|
31 Completed assessments
|
—
|
PRIMARY outcome
Timeframe: Enrollment through six monthsPopulation: Though this was a pre-specified outcome, it was not properly defined prior to starting the pilot. Because this pilot approached intervention testing by delivering different components of the intervention to different individuals, we were unable to clarify the denominator for this measure. Data was not collected for this outcome measure due to a change in intervention delivery. Data for this outcome will not be collected or reported in the future.
We will assess the proportion of intervention components completed, including interventionist completion of screening tools, as well as other tasks outlined in the care plan, including focused education, navigation, and addressing barriers to care, screening.
Outcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: Enrollment through six monthsPopulation: Data for this outcome measure was not collected. Motivational interviewing was planned to be recorded using the OnePass validated tool. This was a feasibility outcome measure which has since been determined to be not feasible because of unanticipated difficulty identifying appropriate conversations to record for analysis. The overall study status has been updated to 'Terminated' to reflect this absence of data. Data will not be collected or reported in the future.
OnePass is a validated tool used to evaluate MI practice and assess fidelity based on review of a single session, using 23 items to assess MI components.61 This tool yields a global score while also identifying specific areas for additional practice and training. Scores range from 1 - 7 with 5 considered a minimum for competence. Interventionists will complete at least one OnePass within a month of starting MI sessions with participants.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Baseline and 3 monthsAutonomy support will be measured with the short form of the Health Care Climate Questionnaire (6 items, range 6 - 42, Cronbach alpha 0.82). Scores on the short form 6-item version are calculated by averaging the individual item scores. Higher average scores represent a higher level of perceived autonomy support.
Outcome measures
| Measure |
Intervention Arm
n=10 Participants
This intervention will combine care coordination and motivational interviewing strategies.
Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
|
People Who Declined Participation
This outcome involves people who declined to participate in this study
|
|---|---|---|
|
Change in Autonomy Support
|
-2.5 units on a scale
Standard Error 11.1
|
—
|
SECONDARY outcome
Timeframe: Baseline and 6 monthsPopulation: 7 participants provided complete data on this measure.
Autonomous motivation will be measured using the Autonomous Motivation and External Regulation scales of the Treatment Self-Regulation Questionnaire (10 items, range 7 - 70, Cronbach alpha 0.90) with a higher score indicating higher emotion regulation strategy.
Outcome measures
| Measure |
Intervention Arm
n=7 Participants
This intervention will combine care coordination and motivational interviewing strategies.
Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
|
People Who Declined Participation
This outcome involves people who declined to participate in this study
|
|---|---|---|
|
Change in Autonomous Motivation
|
-1.1 units on a scale
Standard Deviation 9.9
|
—
|
SECONDARY outcome
Timeframe: 6 monthsThis will include postpartum visits, visits for contraceptive management, routine preventive care visits, and visits to follow-up on complications of pregnancy (secondary prevention). Visits will be abstracted from the health record and from interventionist records.
Outcome measures
| Measure |
Intervention Arm
n=13 Participants
This intervention will combine care coordination and motivational interviewing strategies.
Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
|
People Who Declined Participation
This outcome involves people who declined to participate in this study
|
|---|---|---|
|
Count of Preventive Care Visits
|
2.2 visits
Standard Deviation 1.3
|
—
|
SECONDARY outcome
Timeframe: 6 monthsThis Outcome Measure reports the average percentage of the recommended care plan completed among participants. Recommended care will be abstracted from a care plan completed within the first two weeks after enrollment. Completed care will be abstracted from the health record and from interventionist records.
Outcome measures
| Measure |
Intervention Arm
n=13 Participants
This intervention will combine care coordination and motivational interviewing strategies.
Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
|
People Who Declined Participation
This outcome involves people who declined to participate in this study
|
|---|---|---|
|
Proportion of Recommended Care Completed
|
73 percentage
Standard Deviation 35
|
—
|
Adverse Events
Intervention Arm
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place